×


 x 

Shopping cart
Michael J. Barratt - Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs - 9780470878279 - V9780470878279
Stock image for illustration purposes only - book cover, edition or condition may vary.

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

€ 148.35
FREE Delivery in Ireland
Description for Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs Hardcover. With Viagra the most famous example, drug repositioning has been growing in importance for pharmaceutical companies seeking to reinvigorate development pipelines. This book provides a broad overview of drug repositioning including the business reasons and unique opportunities and challenges. Num Pages: 498 pages, charts. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 240 x 166 x 30. Weight in Grams: 826.

The how's and why's of successful drug repositioning

Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.

Drug Repositioning is divided into three parts:

  • Part 1, Drug Repositioning: Business Case, Strategies, and Operational Considerations, ... Read more

  • Part 2, Application of Technology Platforms to Uncover New Indications and Repurpose Existing Drugs, sets forth computational-based strategies, tools, and databases that have been designed for repositioning studies, screening approaches, including combinations of existing drugs, and a look at the development of chemically modified analogs of approved agents.

  • Part 3, Academic and Non-Profit Initiatives & the Role of Alliances in the Drug Repositioning Industry, explores current investigations for repositioning drugs to treat rare and neglected diseases, which are frequently overlooked by for-profit pharmaceutical companies due to their lack of commercial return.

The book's appendix provides valuable resources for drug repositioning researchers, including information on drug repositioning and reformulation companies, databases, government resources and organizations, regulatory agencies, and drug repositioning initiatives from academia and non-profits.

With this book as their guide, students and pharmaceutical researchers can learn how to use drug repositioning techniques to extend the lifespan and applications of existing drugs as well as maximize the return on investment in drug research and development.

Show Less

Product Details

Format
Hardback
Publication date
2012
Publisher
John Wiley & Sons Inc United Kingdom
Number of pages
498
Condition
New
Number of Pages
498
Place of Publication
New York, United States
ISBN
9780470878279
SKU
V9780470878279
Shipping Time
Usually ships in 7 to 11 working days
Ref
99-50

About Michael J. Barratt
Michael Barratt is an independent consultant and previously?Senior Director and Technology Platform Leader at Pfizer's Global Indications Discovery Research Unit. He has?over 15?years of experience in preclinical drug discovery research and leadership. Donald Frail is an independent consultant and previously?Vice President of Pfizer Global Research and Development and Head of Pfizer's Global Indications Discovery Research Unit. He has ... Read more

Reviews for Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs
“Overall, this book is so complete that it is a must read for all the players in drug repositioning, not only  researches or drug developers, but also business development specialist, investors, venture capital firms, academia and regulators that need a compressive description that will satisfy novice and more experienced professionals.”  (ChemMedChem, 1 March 2013)  

Goodreads reviews for Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs


Subscribe to our newsletter

News on special offers, signed editions & more!